These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 1348219)

  • 21. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Efficacy and tolerance of a 12-week treatment with inhaled formoterol in patients with reversible obstructive lung disease.
    Stålenheim G; Wegener T; Grettve L; Lundbäck B; Melander B; Osterman K; Piitulainen E; Zetterström O
    Respiration; 1994; 61(6):305-9. PubMed ID: 7824809
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
    Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhaled formoterol in the prevention of exercise-induced bronchoconstriction in asthmatic children.
    Boner AL; Spezia E; Piovesan P; Chiocca E; Maiocchi G
    Am J Respir Crit Care Med; 1994 Apr; 149(4 Pt 1):935-9. PubMed ID: 7908246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of a relative therapeutic index between inhaled formoterol and salbuterol in asthma patients.
    Rosenborg J; Larsson P; Rott Z; Böcskei C; Poczi M; Juhász G
    Eur J Clin Pharmacol; 2002 Jul; 58(4):S61-7. PubMed ID: 12214580
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy and safety of budesonide/formoterol single inhaler therapy versus a higher dose of budesonide in moderate to severe asthma.
    Scicchitano R; Aalbers R; Ukena D; Manjra A; Fouquert L; Centanni S; Boulet LP; Naya IP; Hultquist C
    Curr Med Res Opin; 2004 Sep; 20(9):1403-18. PubMed ID: 15383189
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Comparison of the efficacy, tolerability, and safety of formoterol dry powder and oral, slow-release theophylline in the treatment of COPD.
    Rossi A; Kristufek P; Levine BE; Thomson MH; Till D; Kottakis J; Della Cioppa G;
    Chest; 2002 Apr; 121(4):1058-69. PubMed ID: 11948033
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Time course and duration of bronchodilatation with formoterol dry powder in patients with stable asthma.
    Wallin A; Sandström T; Rosenhall L; Melander B
    Thorax; 1993 Jun; 48(6):611-4. PubMed ID: 8346490
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Protective effect and duration of action of inhaled formoterol and salbutamol on exercise-induced asthma in children.
    Henriksen JM; Agertoft L; Pedersen S
    J Allergy Clin Immunol; 1992 Jun; 89(6):1176-82. PubMed ID: 1351489
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Budesonide and formoterol in a single inhaler improves asthma control compared with increasing the dose of corticosteroid in adults with mild-to-moderate asthma.
    Lalloo UG; Malolepszy J; Kozma D; Krofta K; Ankerst J; Johansen B; Thomson NC
    Chest; 2003 May; 123(5):1480-7. PubMed ID: 12740264
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Regular treatment with formoterol for chronic asthma: serious adverse events.
    Cates CJ; Cates MJ; Lasserson TJ
    Cochrane Database Syst Rev; 2008 Oct; (4):CD006923. PubMed ID: 18843738
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of combination inhalers vs inhaled corticosteroids alone in moderate persistent asthma.
    Lee DK; Jackson CM; Currie GP; Cockburn WJ; Lipworth BJ
    Br J Clin Pharmacol; 2003 Nov; 56(5):494-500. PubMed ID: 14651722
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adjustable maintenance dosing with budesonide/formoterol compared with fixed-dose salmeterol/fluticasone in moderate to severe asthma.
    Aalbers R; Backer V; Kava TT; Omenaas ER; Sandström T; Jorup C; Welte T
    Curr Med Res Opin; 2004; 20(2):225-40. PubMed ID: 15006018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. One-year efficacy and safety of inhaled formoterol dry powder in children with persistent asthma.
    Bensch G; Berger WE; Blokhin BM; Socolovsky AL; Thomson MH; Till MD; Castellsague J; Della Cioppa G;
    Ann Allergy Asthma Immunol; 2002 Aug; 89(2):180-90. PubMed ID: 12197575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Bronchodilator effect of inhaled formoterol vs salbutamol over 12 hours.
    Maesen FP; Smeets JJ; Gubbelmans HL; Zweers PG
    Chest; 1990 Mar; 97(3):590-4. PubMed ID: 1968371
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Formoterol. An update of its pharmacological properties and therapeutic efficacy in the management of asthma.
    Bartow RA; Brogden RN
    Drugs; 1998 Feb; 55(2):303-22. PubMed ID: 9506248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long duration of airway but not systemic effects of inhaled formoterol in asthmatic patients.
    Lötvall J; Ankerst J
    Respir Med; 2008 Mar; 102(3):449-56. PubMed ID: 18023335
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Randomised trial comparing as-needed versus regular treatment with formoterol in patients with persistent asthma.
    Richter K; Hartmann U; Metzenauer P; Magnussen H
    Respir Med; 2007 Mar; 101(3):467-75. PubMed ID: 16949264
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The use of inhaled formoterol in the treatment of asthma.
    Berger WE
    Ann Allergy Asthma Immunol; 2006 Jul; 97(1):24-33. PubMed ID: 16892777
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bronchodilator response to albuterol after regular formoterol and effects of acute corticosteroid administration.
    Lipworth BJ; Aziz I
    Chest; 2000 Jan; 117(1):156-62. PubMed ID: 10631214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.